查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1468062

2024-2032 年按放射性核種類型、醫療應用、最終用戶和地區分類的α發射體市場報告

Alpha Emitter Market Report by Type of Radionuclide, Medical Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球α輻射體市場規模達14.768億美元。

阿爾法發射體是放射源發射的物質，在釋放阿爾法粒子後會衰變。它們實現適當的生物分佈和相關的劑量分佈，以實現有效的治療，而不會引起不可接受的急性或長期副作用。 α粒子具有極高的細胞殺傷率，在醫療過程中使用時比BETA粒子對腫瘤細胞更具破壞性。因此，它們對鄰近正常組織造成的損害較小。鐳、鉛和鉍是治療過程中使用的一些放射性核種。 α粒子的短程和高線性能量轉移（LET）使其對醫學研究非常有吸引力，特別是作為一種可行的癌症治療方法。有多種類型的癌症可以用α發射體治療，包括卵巢癌、胰臟癌、淋巴瘤和黑色素瘤。

α發射體市場趨勢：

該市場主要由癌症治療領域進行的廣泛高階研發（R&D）活動所推動。這可以歸因於人們對目標α發射體的細胞殺傷能力的認知不斷增強。與此一致的是，大眾中各種類型癌症的盛行率不斷上升，為市場提供了動力。此外，容易患多種心臟病和癌症疾病的老年人口不斷增加，也為市場創造了積極的前景。此外，醫療機構擴大採用標靶抗癌或阿爾法療法（TAT），正在對市場產生積極影響。持續的技術進步和越來越多的新核醫學產品批准進一步推動了市場。影響市場的其他一些因素包括快速城市化、醫療基礎設施的不斷改善、醫療支出的增加以及個人可支配收入水準的提高。

本報告回答的關鍵問題

  • 2023 年全球 α 發射體市場規模有多大？
  • 2024-2032年全球α發射體市場的預期成長率是多少？
  • 推動全球阿爾法發射體市場的關鍵因素是什麼？
  • COVID-19 對全球 α 發射體市場有何影響？
  • 根據放射性核種的類型，全球 α 發射體市場的分類是怎樣的？
  • 基於醫療應用的全球阿爾法發射體市場的細分是什麼？
  • 全球阿爾法發射體市場的關鍵區域有哪些？
  • 全球阿爾法發射體市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球α發射體市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場細分：依放射性核種類型

  • 砈
    • 市場走向
    • 市場預測
  • 鐳
    • 市場走向
    • 市場預測
  • 錕
    • 市場走向
    • 市場預測
  • 帶領
    • 市場走向
    • 市場預測
  • 鉍
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依醫療應用

  • 攝護腺癌
    • 市場走向
    • 市場預測
  • 骨轉移
    • 市場走向
    • 市場預測
  • 卵巢癌
    • 市場走向
    • 市場預測
  • 胰腺癌
    • 市場走向
    • 市場預測
  • 內分泌腫瘤
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 醫學研究機構
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Actinium Pharmaceuticals Inc.
    • Alpha Tau Medical Ltd.
    • Bayer AG
    • Fusion Pharmaceuticals
    • IBA RadioPharma Solutions
    • RadioMedix Inc.
Product Code: SR112024A6398

The global alpha emitter market size reached US$ 1,476.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 10,975.8 Million by 2032, exhibiting a growth rate (CAGR) of 24.22% during 2024-2032.

Alpha emitters are substances emitted by radioactive sources that decay after releasing alpha particles. They achieve appropriate biodistribution and associated dose distribution to achieve effective therapy without causing unacceptable acute or long-term side effects. With their exceptionally high cell-killing rates, alpha particles are more destructive to tumor cells than beta particles when used in medical procedures. Consequently, they cause less damage to adjacent normal tissues. Radium, lead and bismuth are some of the radionuclides used in the treatment process. The short range and high linear energy transfer (LET) of alpha particles have made them remarkably appealing to medical research, particularly as a viable treatment method for cancer. There are numerous types of cancer that can be treated with alpha emitters, including ovarian cancer, pancreatic cancer, lymphoma, and melanoma.

Alpha Emitter Market Trends:

The market is majorly driven by extensive and high-end research and development (R&D) activities being conducted in cancer treatment. This can be attributed to the growing awareness regarding the cell-killing abilities of targeted alpha emitters. In line with this, the rising prevalence of various types of cancer among the masses is providing an impetus to the market. Also, the increasing geriatric population that is susceptible to develop numerous cardiac and cancer ailments is creating a positive outlook for the market. Moreover, the rising adoption of targeted anticancer or alpha therapy (TAT) in healthcare facilities is impacting the market positively. The market is further propelled by continual technological advancements and the growing number of new nuclear-medicine-based product approvals. Some of the other factors contributing to the market include rapid urbanization, continual improvements in healthcare infrastructure, rising medical expenditure and inflating disposable income levels of the individuals.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global alpha emitter market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type of radionuclide, medical application, and end user.

Breakup by Type of Radionuclide:

Astatine

Radium

Actinium

Lead

Bismuth

Others

Breakup by Medical Application:

Prostate Cancer

Bone Metastasis

Ovarian Cancer

Pancreatic Cancer

Endocrine Tumors

Others

Breakup by End User:

Hospitals

Medical Research Institutions

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Actinium Pharmaceuticals Inc., Alpha Tau Medical Ltd., Bayer AG, Fusion Pharmaceuticals, IBA RadioPharma Solutions and RadioMedix Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global alpha emitter market in 2023?
  • 2. What is the expected growth rate of the global alpha emitter market during 2024-2032?
  • 3. What are the key factors driving the global alpha emitter market?
  • 4. What has been the impact of COVID-19 on the global alpha emitter market?
  • 5. What is the breakup of the global alpha emitter market based on the type of radionuclide?
  • 6. What is the breakup of the global alpha emitter market based on the medical application?
  • 7. What are the key regions in the global alpha emitter market?
  • 8. Who are the key players/companies in the global alpha emitter market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Alpha Emitter Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type of Radionuclide

  • 6.1 Astatine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radium
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Actinium
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Lead
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Bismuth
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Medical Application

  • 7.1 Prostate Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bone Metastasis
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ovarian Cancer
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pancreatic Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Endocrine Tumors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Research Institutions
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Actinium Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Alpha Tau Medical Ltd.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Pharmaceuticals
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 IBA RadioPharma Solutions
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 RadioMedix Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio

List of Figures

  • Figure 1: Global: Alpha Emitter Market: Major Drivers and Challenges
  • Figure 2: Global: Alpha Emitter Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Alpha Emitter Market: Breakup by Type of Radionuclide (in %), 2023
  • Figure 5: Global: Alpha Emitter Market: Breakup by Medical Application (in %), 2023
  • Figure 6: Global: Alpha Emitter Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Alpha Emitter Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Alpha Emitter (Astatine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Alpha Emitter (Astatine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Alpha Emitter (Radium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Alpha Emitter (Radium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Alpha Emitter (Actinium) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Alpha Emitter (Actinium) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Alpha Emitter (Lead) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Alpha Emitter (Lead) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Alpha Emitter (Bismuth) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Alpha Emitter (Bismuth) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Alpha Emitter (Other Type of Radionuclides) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Alpha Emitter (Other Type of Radionuclides) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Alpha Emitter (Prostate Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Alpha Emitter (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Alpha Emitter (Bone Metastasis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Alpha Emitter (Bone Metastasis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Alpha Emitter (Ovarian Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Alpha Emitter (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Alpha Emitter (Pancreatic Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Alpha Emitter (Pancreatic Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Alpha Emitter (Endocrine Tumors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Alpha Emitter (Endocrine Tumors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Alpha Emitter (Other Medical Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Alpha Emitter (Other Medical Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Alpha Emitter (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Alpha Emitter (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Alpha Emitter (Medical Research Institutions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Alpha Emitter (Medical Research Institutions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Alpha Emitter (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Alpha Emitter (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Alpha Emitter Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Alpha Emitter Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Alpha Emitter Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Alpha Emitter Industry: SWOT Analysis
  • Figure 88: Global: Alpha Emitter Industry: Value Chain Analysis
  • Figure 89: Global: Alpha Emitter Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Alpha Emitter Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Alpha Emitter Market Forecast: Breakup by Type of Radionuclide (in Million US$), 2024-2032
  • Table 3: Global: Alpha Emitter Market Forecast: Breakup by Medical Application (in Million US$), 2024-2032
  • Table 4: Global: Alpha Emitter Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Alpha Emitter Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Alpha Emitter Market: Competitive Structure
  • Table 7: Global: Alpha Emitter Market: Key Players